{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":27,"description":"Propylene Glycol-Free Melphalan Hydrochloride (Evomela) administered intravenously at 70-100 mg/m2/day on Days -3 and -2 prior to autologous stem cell transplantation\n\nPropylene Glycol-Free Melphalan Hydrochloride: Intravenous Propylene Glycol-Free Melphalan Hydrochloride","id":"EG000","otherNumAffected":25,"otherNumAtRisk":27,"seriousNumAffected":20,"seriousNumAtRisk":27,"title":"Evomela"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":27,"numEvents":25}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":27,"numEvents":20}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":27,"numEvents":22}],"term":"Fatigue"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"New cardiac arrhythmias","organSystem":"Cardiac disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":4}],"term":"Cardiac arrhythmias"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2}],"term":"Renal dysfunction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":27,"numEvents":14}],"term":"Autonomic dysfunction"}],"timeFrame":"12 months"}